US EditionTrump Orders Drug Stockpile, Increased Manufacturing
- President Trump signed an executive order to fill the Strategic Active Pharmaceutical Ingredients Reserve with critical drug components.
- The order directs the Office of the Assistant Secretary for Preparedness and Response to identify approximately 26 critical drugs for national health and security.
- The White House emphasized that overreliance on foreign nations for key materials risks shortages of essential medicines.
- Senator Roger Marshall stated that it's vital to be independent, referring to the risks associated with dependency on pharmaceutical ingredients from foreign nations.
27 Articles
27 Articles
Daily Journal
Trump orders drug stockpile, increased manufacturing
(The Center Square) – President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the United States.
Trump’s Push for U.S. Drug Manufacturing Expands to Pharma Ingredients With New Executive Order
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing Expands to Pharma Ingredients With New Executive O…
Trump Orders Creation of Domestic Stockpile for Key Drug Ingredients
WASHINGTON, D.C. – President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the United States. His executive order provides for a six month supply of the active pharmaceutical ingredients in each drug to be added to the Strategic Active Pharmaceutical Reserve. “Stockpiling APIs is advantageous as APIs are generally lower-cost and have longer shelf lives than the finished drug products th…
Administration orders six-month stockpile of ingredients for domestic drug supply
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response to develop a list of 26 drugs considered critical for national health and security. The order calls for the ASPR to gather a six-month supply of drug ingredients and place them in the Strategic Active Pharmaceutical Ingredients Reserve with a preference for domestic sourcing an…
Coverage Details
Bias Distribution
- 46% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
